Hypertension in periand postmenopausal women: mechanisms, management, observation

QR Code

Hypertension in periand postmenopausal women: mechanisms, management, observation

An important role in the development and evolution of hypertension in females is applied to sex hormones. Estrogen deficiency and hyperandrogenism, characteristic of periand postmenopause, are links in the pathogenesis of hypertension in this period of a woman's life and are accompanied by an i...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. A. Polyakova, A. O. Konradi, E. I. Baranova, A. S. Galyavich, Y. V. Zhernakova, T. N. Novikova, N. I. Tapilskaya, O. N. Tkacheva, O. D. Ostroumova, V. V. Skibitsky, G. A. Chumakova
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2024-02-01
Series:	Российский кардиологический журнал
Subjects:	essential hypertension estrogens perimenopause postmenopause sympathetic hyperactivity obesity moxonidine
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/5729
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Hypertension in peri- and postmenopausal women — pathophysiological mechanisms and approaches to treatment
by: E. I. Baranova, et al.
Published: (2023-06-01)

Modern ideas about the consequences of sympathoadrenal hyperactivation in hypertensive patients with metabolic disorders: modulation possibilities
by: Yu. V. Zhernakova
Published: (2023-12-01)

Pathogenetic mechanisms of postmenopausal osteoporosis formation and their relationship with cardiovascular pathology
by: G. V. Poryadin, et al.
Published: (2022-04-01)

An imidazoline receptor agonist, moxonidine, in optimization of arterial hypertension treatment among postmenopausal women
by: A. B. Bakhshaliev, et al.
Published: (2006-02-01)

Estrogenic receptors a and p gene polymorphisms in postmenopausal osteoporosis
by: K A Maslova, et al.
Published: (2008-06-01)

Knowledge, Attitudes, and Prevalence of Menopausal Symptoms among Perimenopausal and Postmenopausal Women – A Mixed Method Study from Tamil Nadu
by: Giddaluru Bhavya Muralikrishna, et al.
Published: (2025-04-01)

ADDITIONAL BENEFITS OF ANTIHYPERTENSIVE MOXONIDINE THERAPY IN POSTMENOPAUSAL WOMEN WITH ARTERIAL HYPERTENSION
by: E. N. Dudinskaya, et al.
Published: (2014-02-01)

Losartan in postmenopausal women with essential arterial hypertension
by: O. N. Tkacheva, et al.
Published: (2010-12-01)

WHO Study Group on assessment of fracture risk and its application to screening for postmenopausal osteoporosis : report of a WHO study group.
Published: (1994)

Effectiveness of radiofrequency renal denervation in diseases with increased sympathetic nervous system activity
by: B. A. Rudenko, et al.
Published: (2022-01-01)

A systematic analysis of vascular paroxysm pathophysiology in perimenopause: methods for nutritional correction
by: O. A. Gromova, et al.
Published: (2020-09-01)

Paroxysmal Sympathetic Hyperactivity Syndrome (Review)
by: L. M. Tsentsiper, et al.
Published: (2022-08-01)

Paroxysmal sympathetic hyperactivity in brain damage (scientific review). Part 2
by: O.V. Kravets, et al.
Published: (2025-05-01)

OSTEOPOROSIS: ASSESSMENT OF A RISK FOR RECURRENT LOW-TRAUMA FRACTURES IN POSTMENOPAUSAL WOMEN
by: O. V. Dobrovolskaya, et al.
Published: (2016-03-01)

Using Heart Rate Variability Monitoring for Dexmedetomidine Dosing in Neurointensive Care Patients
by: Yu. Yu. Kiryachkov, et al.
Published: (2021-02-01)

Features of the course of menopause in women under chronic stress: An observational cohort study
by: T. L. Botasheva, et al.
Published: (2024-08-01)

Influence of catheter-based renal denervation on carbohydrate metabolism in patients with diabetes and hypertension
by: D. A. Feshchenko, et al.
Published: (2023-01-01)

Approaches to the treatment of uncontrolled hypertension. Place of the Physiotens®
by: S. N. Tereshchenko, et al.
Published: (2021-07-01)

Moxonidine in combined therapy of essential arterial hypertension patients with chronic obstructive pulmonary disease
by: N. R. Paleev, et al.
Published: (2006-08-01)

A digital solution for determining the severity of paroxysmal sympathetic hyperactivity syndrome in patients with brain injury
by: L. M. Tsentsiper, et al.
Published: (2023-12-01)

LIPID STATUS IN PERIAND POSTMENOPAUSAL WOMEN WITH INSOMNIA
by: L. I. Kolesnikova, et al.
Published: (2012-05-01)

Postmenopausal endometrial screening at primary healthcare
by: A. I. Ischenko, et al.
Published: (2016-06-01)

Ovarian Cysts in Menopausal Women (Literature Review)
by: S. F. Taychinova, et al.
Published: (2019-07-01)

Quality of life assessment in perimenopausal women with abnormal uterine bleeding and endometrial hyperplasia
by: F. V. Abdiyeva
Published: (2021-01-01)

Hypobarotherapy and cardiovascular risk factor correction in women in early postmenopause
by: S. K. Kshnyaseva, et al.
Published: (2012-10-01)

Monitoring of the Effectiveness of Intensive Care and Rehabilitation by Evaluating the Functional Activity of the Autonomic Nervous System in Patients with Brain Damage
by: Yu. Yu. Kiryachkov, et al.
Published: (2018-09-01)

Postoperative transient sympathetic storm after endoscopic third ventriculostomy with choroid plexus cauterization in pediatric hydrocephalus
by: Genrui Guo, et al.
Published: (2025-07-01)

Moexipril in arterial hypertension treatment among postmenopausal women with osteoporosis
by: O. D. Ostroumova, et al.
Published: (1970-01-01)

Imidazoline receptor agonist moxonidine and arterial hypertension treatment in women with menopausal metabolic syndrome
by: E. V. Tishina, et al.
Published: (2011-06-01)

ENDOMETRIOSIS IN A POSTMENOPAUSAL WOMAN
by: IGOR S. Zakharov, et al.
Published: (2017-09-01)

MOLECULAR GENETIC TESTING OF OSTEOPOROSIS SUSCEPTIBILITY IN POSTMENOPAUSAL WOMEN IN MOSCOW
by: V A Myakotkin, et al.
Published: (2011-04-01)

Cardiac arrhythmia prevalence in postmenopausal women
by: N. V. Izmozherova, et al.
Published: (2011-06-01)

The influence of individual genetic polymorphisms on postmenopausal osteoporosis treatment effectiveness
by: N. A. Reznichenko, et al.
Published: (2020-12-01)

Clinical characteristics of postmenopausal women with endometrial polyps
by: E. G. Kobaidze, et al.
Published: (2022-07-01)

Therapeutic aspects of hormone replacement therapy in postmenopausal women with metabolic syndrome: cardiologist’s opinion
by: T. V. Adasheva, et al.
Published: (2009-08-01)

Precancerous and malignant diseases of the endometrium in patients with endometrial polyps in postmenopause
by: T. V. Klinyshkova, et al.
Published: (2025-05-01)

Optimizing antihypertensive therapy in postmenopausal women with metabolic syndrome
by: O. N. Poryvkina, et al.
Published: (2009-06-01)

Protective effects of major royal jelly proteins on reproductive function of mice during perimenopausal period
by: LIU Xin, et al.
Published: (2019-12-01)

HYPERTENSION IN POSTMENOPAUSAL WOMEN: RATIONALE FOR THE USE OF CALCIUM CHANNEL BLOCKERS IN ANTIHYPERTENSIVE THERAPY
by: O. A. Kislyak, et al.
Published: (2017-07-01)

Moxonidine-based combination antihypertensive therapy in patients with metabolic syndrome
by: E. V. Tishina, et al.
Published: (2012-06-01)